Alpha 2.0
Login Register
» Authors » Jan Brouwer

Jan Brouwer

Explore the profile of Jan Brouwer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 145
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Pathology
Physiology
Top 10 Co-Authors
Sjoerd H Hofma
Vera H M Deneer
Matthijs A Velders
Simone W A van Haarlem
Anne S R van Lindert
Michel Quere
Alexandra Ten Heuvel
Corine de Jong
Toine C G Egberts
Adrianus J van Boven
Published In
Eur J Heart Fail
J Clin Microbiol
EuroIntervention
Int J Gynecol Pathol
Genes (Basel)
Affiliations
Soon will be listed here.
Recent Articles
1.
Impact of symptom duration and mechanical circulatory support on prognosis in cardiogenic shock complicating acute myocardial infarction
Klein F, Crooijmans C, Peters E, van t Veer M, Timmermans M, Henriques J, et al.
Neth Heart J . 2024 Jul; 32(7-8):290-297. PMID: 38955979
Background: Mortality rates in patients with cardiogenic shock complicating acute myocardial infarction (AMICS) remain high despite advancements in AMI care. Our study aimed to investigate the impact of prehospital symptom...
2.
Maximum a posteriori detection of heartbeats from a chest-worn accelerometer
Schipper F, Van Sloun R, Grassi A, Brouwer J, van Meulen F, Overeem S, et al.
Physiol Meas . 2024 Mar; 45(3). PMID: 38430565
. Unobtrusive long-term monitoring of cardiac parameters is important in a wide variety of clinical applications, such as the assesment of acute illness severity and unobtrusive sleep monitoring. Here we...
3.
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of Pathogenic Variants: Prevalence and Clinical Factors
Stroot I, Brouwer J, Bart J, Hollema H, Stommel-Jenner D, Wagner M, et al.
J Clin Oncol . 2023 Feb; 41(14):2523-2535. PMID: 36809028
Purpose: To investigate the prevalence of and clinical factors associated with high-grade serous carcinoma (HGSC) at risk-reducing salpingo-oophorectomy (RRSO) in asymptomatic -pathogenic variant (PV) carriers. Patients And Methods: We included...
4.
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy
de Jong C, Herder G, van Haarlem S, van der Meer F, van Lindert A, Ten Heuvel A, et al.
Genes (Basel) . 2023 Jan; 14(1). PMID: 36672910
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, disabling side effect in non-small cell lung cancer (NSCLC) patients treated with platinum-based therapy. There is increasing evidence for associations between genetic...
5.
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients
de Jong C, Chargi N, Herder G, van Haarlem S, van der Meer F, van Lindert A, et al.
J Cachexia Sarcopenia Muscle . 2022 Mar; 13(3):1554-1564. PMID: 35301821
Background: Chemotherapy-induced toxicities frequently occur in non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. Low skeletal muscle mass (SMM) has been associated with a higher incidence of toxicities...
6.
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study
Zazuli Z, de Jong C, Xu W, Vijverberg S, Masereeuw R, Patel D, et al.
J Pers Med . 2021 Nov; 11(11). PMID: 34834585
This study aims to evaluate genetic risk factors for cisplatin-induced nephrotoxicity by investigating not previously studied genetic risk variants and further examining previously reported genetic associations. A genome-wide study (GWAS)...
7.
Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression
Brouwer J, Strickland K, Ning G, Schmelkin C, Kolin D, Hecht J, et al.
Int J Gynecol Pathol . 2019 Oct; 39(2):163-169. PMID: 31574529
Epithelial proliferations in the fallopian tube have been characterized by some as stem cell outgrowths (SCOUTs) and divided into type I and type II. Type II SCOUTs exhibit diffuse cellular...
8.
Serous tubal intraepithelial neoplasia: the concept and its application
Meserve E, Brouwer J, Crum C
Mod Pathol . 2017 Jan; 30(5):710-721. PMID: 28106106
In recent years it has become clear that many extra-uterine (pelvic) high-grade serous carcinomas (serous carcinomas) are preceded by a precursor lesion in the distal fallopian tube. Precursors range from...
9.
Small RNA sequencing reveals a comprehensive miRNA signature of BRCA1-associated high-grade serous ovarian cancer
Brouwer J, Kluiver J, de Almeida R, Modderman R, Terpstra M, Kok K, et al.
J Clin Pathol . 2016 Apr; PMID: 27048682
Aims: BRCA1 mutation carriers are at increased risk of developing high-grade serous ovarian cancer (HGSOC), a malignancy that originates from fallopian tube epithelium. We aimed to identify differentially expressed known...
10.
Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial
Hofma S, Smits P, Brouwer J, Velders M, van t Hof A, Quere M, et al.
EuroIntervention . 2015 Jan; 10(11):1280-3. PMID: 25572025
Aims: Evaluation of the long-term safety and efficacy of second-generation everolimus-eluting stents (EES) versus first-generation sirolimus-eluting stents (SES) in acute myocardial infarction (AMI) patients. Methods And Results: Six hundred and...